We included 73 long-term patients with post-COVID-19 cognitive symptoms, such as mental confusion, inability to concentrate, forgetfulness, and difficulty remembering desired words or thoughts. These symptoms had persisted for more than 3 months after a flared viral infection, a debilitating disease that affects up to 30% of COVID patients.
Study participants were divided into two organizations: 37 patients gained hyperbaric oxygen treatment and 36 were designated in the simulation-controlled organization (placebo sessions gained air).
Those who consistently gained with baric oxygen had 40 daily treatment sessions, or five sessions per week over a two-month period. sea level, for 90 minutes with oxygen fluctuations.
According to the study’s findings, patients treated with hyperbaric oxygen had “a significant improvement in their overall cognitive function and a more cognitive improvement similar to their broken brain regions expressly guilty of attention and executive function. “Patients also saw a significant improvement in their energy, sleep, psychiatric symptoms, etc.
Participants who only won the placebo remedy did not enjoy a significant improvement in their persistent COVID symptoms.
The study was conducted through the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University.
“The study found that HBOT (hyperbaric oxygen therapy) can induce structural and functional repair of broken brain regions and cognitive, behavioral and emotional functions in unfortunate patients suffering from post-COVID-19 conditions,” said Shai Efrati. Head of the Research Group and Director of the Sagol Center and Chairman of the Medical Advisory Board of Aviv Scientific.
Earlier this year, Efrati and others published an individual case report on long-term hyperbaric oxygen treatment. treated with hyperbaric oxygen therapy.
When it comes to the man’s physical improvement, there was a 34% increase in his maximum oxygen fed with training and a 44% improvement in his forced significant capacity.
“We present the first case of prolonged COVID symptoms effectively treated with hyperbaric oxygen treatment with innovations in cognition and cardiopulmonary function,” the scientists wrote earlier this year. this is a singles case report, additional prospective randomised studies are needed.
Please indicate the appropriate maximum category to facilitate the processing of your request
Thank you for taking the time to provide your feedback to the editors.
Your opinion is for us. However, we do not guarantee individual responses due to the large volume of messages.